However, these differences did not achieve significance at a cluster or bubble level between responders and nonresponders, likely due to small sample size and a stringent correction for multiple comparison ( supplemental Figure 4 B).
← all excerpts
Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study.
1
—
—